BOLD Q2 2024 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena

BOLDBoundless Bio, Inc.

$26M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$265,000

Operating Income

-$19M

Net Income

-$17M

EPS (Diluted)

$-0.77

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$18M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$188M

Total Liabilities

$9M

Stockholders' Equity

$179M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$265,000	$0	—
Operating Income	-$19M	-$14M	-38.9%
Net Income	-$17M	-$12M	-36.9%